Fees for Sanitation Inspections of Cruise Ships, 36812-36813 [E6-10174]
Download as PDF
<![CDATA[
36812
Federal Register / Vol. 71, No. 124 / Wednesday, June 28, 2006 / Notices
Dated: June 20, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–10173 Filed 6–27–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
for vessel sanitation inspections
beginning fiscal year 2007.
SUMMARY: CDC began charging fees to
conduct sanitation inspections of cruise
vessels in 1988. The purpose of these
charges is to recover full costs of
operating the Vessel Sanitation Program.
CDC is requesting comments to the
modified fee schedule; the modified fee
schedule includes an additional vessel
size, the ‘‘mega-sized’’ vessel, for any
vessel that is greater than 120,000 Gross
Registered Tons (GRT). A modified fee
schedule would go into effect in the
beginning of the next fiscal year,
October 2007.
Submit all comments on or before
August 1, 2006.
DATE:
Centers for Disease Control and
Prevention
Send comments to: David L.
Forney, Chief, Vessel Sanitation
Program, National Center for
Environmental Health/VSP, Centers for
Disease Control, 4770 Buford Highway,
NE., Mailstop F–23, Atlanta, Georgia
30341–3724; Telephone: (770) 488–
7333; E-mail: Dforney@cdc.gov.
ADDRESSES:
Fees for Sanitation Inspections of
Cruise Ships
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
Request for public comment on
proposed modification of fee structure
ACTION:
2. Average cost per inspection x
Approximate cost ($US) Per GRT = pership inspection cost.
To get the per-ship inspection cost:
1. Divide the total operating cost of
VSP by estimated number of inspections
to get the average cost per inspection
and then;
2. Multiply the average inspection
cost by a factor based on the ship size/
cost factor to arrive at an approximate
per-ship inspection cost.
The size/cost factor was established in
the proposed fee schedule published in
the Federal Register on July 17, 1987
(52 FR 27060), and revised in a schedule
published in the Federal Register on
November 28, 1989 (54 FR 48942). The
proposed revised size/cost factor is
presented in Appendix A.
Applicability
The fees will apply to all passengers
cruise vessels for which inspections are
conducted as part of CDC’s VSP.
Dated: June 20, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention (CDC).
Appendix A
jlentini on PROD1PC65 with NOTICES
SIZE/COST FACTOR
The CDC conducts sanitation
inspections of passenger cruise ships
under 42 CFR 71.41.
The fee schedule for sanitation
inspections of passenger cruise ships
inspected under the Vessel Sanitation
Program (VSP) was first published in
the Federal Register on November 24,
16:52 Jun 27, 2006
Jkt 208001
Vessel
size
Extra
Small ...
Small .......
Medium ...
PO 00000
Frm 00060
GRT 1
< 3,001
3,001–15,000
15,001–30,000
Fmt 4703
Proposed Modifications to the Fee
Schedule
The proposed modification to the fee
schedule adds a mega-category ship
which includes any vessel greater than
120,000 GRT. In 2007, approximately
eight ships will meet this criterion.
Formula for the Fee Schedule
rage cost
= aveinspection per
1987 (52 FR 45019), and CDC began
collecting fees on March 1, 1988. The
fee structure covers the operating cost of
the VSP which includes salaries,
benefits, travel and per diem, supplies,
contract services, printing, shipping,
average equipment and instrument
requirements, and appropriate support
costs.
Background
The purpose of revising the fee
schedule is to cover increasing
operational costs of the Vessel
Sanitation Program. Because of the
significant increase in complexity and
size, mega-category vessels will require
more inspectors in order to conduct a
comprehensive sanitation inspection
within the timeframe that a vessel is in
port. Currently, the extra large category
(i.e. all ships greater than 60,000 GRT)
is the largest vessel category in the fee
schedule. When the schedule was
created in 1988, no vessels larger than
60,000 GRT existed. VSP is proposing
the revised fee schedule to
accommodate the current trends in
vessel size and complexity.
The formula used to determine the
fees is as follows:
SUPPLEMENTARY INFORMATION:
total cost of VSP
weighted number of annual
inspections
1.
VerDate Aug<31>2005
Purpose
Sfmt 4703
Approximate
cost ($US)
per GRT
0.25
0.50
1.00
SIZE/COST FACTOR—Continued
Vessel
size
Large .......
Extra
Large ...
Mega* .....
GRT 1
Approximate
cost ($US)
per GRT
30,001–60,000
1.50
60,000–120,000
>120,001
2.00
2.50
*New Vessel Size Category.
1 Gross register tonnage in cubic feet, as
shown in Lloyd’s Register of Shipping.
EXAMPLE FEE SCHEDULE
[Based on fiscal year 2006 Fees]
Vessel
size
Extra
Small ...
Small .......
Medium ...
Large .......
Extra
Large ...
Mega* .....
GRT 1
Fee ($U.S.)
< 3,000
3,001–15,000
15,001–30,000
30,001–60,000
1,300
2,600
5,200
7,800
60,001–120,000
>120,001
10,400
15,600
*New Vessel Size Category.
1 Gross register tonnage in cubic feet, as
shown in Lloyd’s Register of Shipping.
E:\FR\FM\28JNN1.SGM
28JNN1
EN28JN06.001</MATH>
Business: Dr. Conrad Quinn, Division
of Bacterial and Mycotic Diseases,
National Center for Infectious Diseases,
Centers for Disease Control and
Prevention (CDC), 1600 Clifton R., NE.,
Mail Stop E–51, Atlanta, GA 30333.
Telephone (404) 639–2858, e-mail at
CQUINN@CDC.GOV.
Federal Register / Vol. 71, No. 124 / Wednesday, June 28, 2006 / Notices
Inspections and reinspections involve the
same procedure, require the same amount of
time, and are therefore charged at the same
rate.
[FR Doc. E6–10174 Filed 6–27–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Blood Products Advisory Committee;
Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
jlentini on PROD1PC65 with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). At least one portion of the
meeting will be closed to the public.
Name of Committee: Blood Products
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on July 13, 2006, from 8 a.m. to
4:30 p.m. and on July 14, 2006, from 8
a.m. to 3:30 p.m.
Location: Hilton Hotel, Washington
DC North/Gaithersburg, 620 Perry Pkwy,
Gaithersburg, MD 20877.
Contact Person: Donald W. Jehn, or
Pearline K. Muckelvene, Center for
Biologics Evaluation and Research
(CBER), Food and Drug Administration,
1401 Rockville Pike, Rockville, MD
20852, 301–827–0314, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), code
3014519516. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: On July 13, 2006, the
Committee will hear updates on the
following topics: (1) Summary of the
Department of Health and Human
Services Advisory Committee on Blood
Safety and Availability meeting held on
May 9 and 10, 2006; (2) summary of
workshop on testing for malarial
infections in blood donors to be held on
July 12, 2006; (3) Committee report on
the office of blood research and review
site visit, review of intramural research;
(4) west nile virus update and (5) FDA
acceptance criteria for in vivo red blood
cell survival studies. The Committee
will discuss the FDA review of Nabi
Biopharmaceuticals’ Hepatitis B
Immunoglobulin Intravenous (IGIV) for
prevention of recurrent Hepatitis B
Virus (HBV) disease after orthotopic
VerDate Aug<31>2005
16:52 Jun 27, 2006
Jkt 208001
liver transplantation. In the afternoon
the Committee will hear an overview of
the research program of the Laboratory
of Bacterial, Parasitic and
Unconventional Agents, Division of
Emerging and Transfusion Transmitted
Diseases, OBRR, CBER. On July 14,
2006, from 8 a.m. to 3:30 p.m. the
meeting will be closed to permit
discussion and review of trade secret
and/or confidential information (5
U.S.C. 552b(c)(4)).
Procedure: On July 13, 2006, from 8
a.m. to 3:30 p.m., the meeting is open
to the public. Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before July 5, 2006. Oral
presentations from the public will be
scheduled between approximately 11
a.m. to 11:30 a.m. and 3 p.m. to 3:30
p.m. on July 13, 2006. Time allotted for
each presentation may be limited. Those
desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before July 5,
2006.
Closed Committee Deliberations: On
July 13, 2006, between 3:30 p.m. and
4:30 p.m. the meeting will be closed to
permit discussion of information of a
personal nature where disclosure would
constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c) (6)). The Committee will discuss
a review of the individual research
programs. On July 14, 2006, the meeting
will be closed to permit discussion and
review of trade secret and/or
confidential information (5 U.S.C.
552b(c) (4)). This portion of the meeting
will be closed to permit discussion of
this material.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Donald W.
Jehn or Pearline K. Muckelvene at least
7 days in advance of the meeting.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
36813
Dated: June 20, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. 06–5870 Filed 6–27–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006D–0254]
Draft Guidance for Industry: Analytical
Methods Description for Type C
Medicated Feeds; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of draft guidance for
industry (#137) entitled ‘‘Analytical
Methods Description for Type C
Medicated Feeds.’’ This draft guidance
provides our recommendations for
describing methods for analyzing new
animal drugs in Type C medicated
feeds.
Submit written or electronic
comments on this draft guidance by
September 11, 2006 to ensure their
adequate consideration in preparation of
the final document. General comments
on agency guidance documents are
welcome at any time.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Communications Staff (HFV–12), Center
for Veterinary Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Submit written comments on the draft
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Comments
should be identified with the full title
of the draft guidance and the docket
number found in brackets in the
heading of this document. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance document.
FOR FURTHER INFORMATION CONTACT:
Rebecca L. Owen, Center for Veterinary
Medicine (HFV–141), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–276–9842, email: rebecca.owen@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
DATES:
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 71, Number 124 (Wednesday, June 28, 2006)]
[Notices]
[Pages 36812-36813]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-10174]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Fees for Sanitation Inspections of Cruise Ships
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for public comment on proposed modification of fee
structure for vessel sanitation inspections beginning fiscal year 2007.
-----------------------------------------------------------------------
SUMMARY: CDC began charging fees to conduct sanitation inspections of
cruise vessels in 1988. The purpose of these charges is to recover full
costs of operating the Vessel Sanitation Program. CDC is requesting
comments to the modified fee schedule; the modified fee schedule
includes an additional vessel size, the ``mega-sized'' vessel, for any
vessel that is greater than 120,000 Gross Registered Tons (GRT). A
modified fee schedule would go into effect in the beginning of the next
fiscal year, October 2007.
DATE: Submit all comments on or before August 1, 2006.
ADDRESSES: Send comments to: David L. Forney, Chief, Vessel Sanitation
Program, National Center for Environmental Health/VSP, Centers for
Disease Control, 4770 Buford Highway, NE., Mailstop F-23, Atlanta,
Georgia 30341-3724; Telephone: (770) 488-7333; E-mail: Dforney@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose
The purpose of revising the fee schedule is to cover increasing
operational costs of the Vessel Sanitation Program. Because of the
significant increase in complexity and size, mega-category vessels will
require more inspectors in order to conduct a comprehensive sanitation
inspection within the timeframe that a vessel is in port. Currently,
the extra large category (i.e. all ships greater than 60,000 GRT) is
the largest vessel category in the fee schedule. When the schedule was
created in 1988, no vessels larger than 60,000 GRT existed. VSP is
proposing the revised fee schedule to accommodate the current trends in
vessel size and complexity.
Proposed Modifications to the Fee Schedule
The proposed modification to the fee schedule adds a mega-category
ship which includes any vessel greater than 120,000 GRT. In 2007,
approximately eight ships will meet this criterion.
Formula for the Fee Schedule
The formula used to determine the fees is as follows:
[GRAPHIC] [TIFF OMITTED] TN28JN06.001
2. Average cost per inspection x Approximate cost ($US) Per GRT =
per-ship inspection cost.
To get the per-ship inspection cost:
1. Divide the total operating cost of VSP by estimated number of
inspections to get the average cost per inspection and then;
2. Multiply the average inspection cost by a factor based on the
ship size/cost factor to arrive at an approximate per-ship inspection
cost.
The size/cost factor was established in the proposed fee schedule
published in the Federal Register on July 17, 1987 (52 FR 27060), and
revised in a schedule published in the Federal Register on November 28,
1989 (54 FR 48942). The proposed revised size/cost factor is presented
in Appendix A.
Background
The CDC conducts sanitation inspections of passenger cruise ships
under 42 CFR 71.41.
The fee schedule for sanitation inspections of passenger cruise
ships inspected under the Vessel Sanitation Program (VSP) was first
published in the Federal Register on November 24, 1987 (52 FR 45019),
and CDC began collecting fees on March 1, 1988. The fee structure
covers the operating cost of the VSP which includes salaries, benefits,
travel and per diem, supplies, contract services, printing, shipping,
average equipment and instrument requirements, and appropriate support
costs.
Applicability
The fees will apply to all passengers cruise vessels for which
inspections are conducted as part of CDC's VSP.
Dated: June 20, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention
(CDC).
Appendix A
Size/Cost Factor
------------------------------------------------------------------------
Approximate
Vessel size GRT \1\ cost ($US)
per GRT
------------------------------------------------------------------------
Extra Small............................. < 3,001 0.25
Small................................... 3,001-15,000 0.50
Medium.................................. 15,001-30,000 1.00
Large................................... 30,001-60,000 1.50
Extra Large............................. 60,000-120,000 2.00
Mega*................................... >120,001 2.50
------------------------------------------------------------------------
*New Vessel Size Category.
\1\ Gross register tonnage in cubic feet, as shown in Lloyd's Register
of Shipping.
Example Fee Schedule
[Based on fiscal year 2006 Fees]
------------------------------------------------------------------------
Vessel size GRT \1\ Fee ($U.S.)
------------------------------------------------------------------------
Extra Small............................. < 3,000 1,300
Small................................... 3,001-15,000 2,600
Medium.................................. 15,001-30,000 5,200
Large................................... 30,001-60,000 7,800
Extra Large............................. 60,001-120,000 10,400
Mega*................................... >120,001 15,600
------------------------------------------------------------------------
*New Vessel Size Category.
\1\ Gross register tonnage in cubic feet, as shown in Lloyd's Register
of Shipping.
[[Page 36813]]
Inspections and reinspections involve the same procedure,
require the same amount of time, and are therefore charged at the
same rate.
[FR Doc. E6-10174 Filed 6-27-06; 8:45 am]
BILLING CODE 4163-18-P
